ORTHOCLONE OKT3®

(Muromonab CD3)

Documentation

Patented
Approved 1985
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Agonist
Target: CD3
Indication Category: Transplants

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA